Through this collaboration, Daiichi Sankyo and Lilly will reinforce the World Heart Federation’s efforts addressing the challenges that result from a cardiac event, such as a heart attack or stent placement. In particular, the organizations will work together in emphasizing the importance of a heart healthy lifestyle and adherence to medications for acute coronary syndrome patients.
Acute coronary syndrome is an umbrella term that includes unstable angina (chest pain) and myocardial infarction (heart attack).
Pekka Puska, president of the World Heart Federation, said: “We find that people who have experienced a cardiac event often struggle to cope with the physical and emotional impact. This collaboration will support patients in making the lifestyle changes that are critical during the recovery process and beyond.”